NCT07151040
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07151040
Title Phase 1/2 Study to Evaluate TH9619 in the Treatment of Advanced Solid Tumors (ODIN)
Acronym ODIN
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors One-carbon Therapeutics AB
Indications
Therapies
Age Groups: senior | adult
Covered Countries GBR | FRA | ESP


No variant requirements are available.